Rayls Taps Enzyme Finance to Grow Institutional Yield Framework
Rayls, a renowned blockchain network for banking entities, has partnered with Enzyme Finance, a popular decentralized infrastructure platform. The partnership attempts to accelerate institutional-scale yield distribution. As per Rayls official social media announcement, the development addresses the wider infrastructure required for the on-chain onboarding of institutional assets. So, this move denotes the significance of developing a thorough operating stack dealing with institutional assets. Institutional yield distribution needs more than vault standards alone.@enzymefinance is joining Rayls as a launch partner, adding fund infrastructure to the ecosystem across issuance, structuring, administration, NAV accounting, subscription management, and institutional fee… pic.twitter.com/HiXqS1RRNm — Rayls (@RaylsLabs) April 28, 2026 Rayls and Enzyme Join Forces to Grow On-Chain Infrastructure for Institutional Yield The partnership between Rayls and Enzyme Finance focuses on improving the capability to back institutional-level operations on-chain. For this purpose, Enzyme Finance will offer fund infrastructure across structuring, issuance, NAV accounting, institutional fees, and subscription management frameworks. The inclusion of fund infrastructure permits Rayls to streamline procedures like structuring and issuance, guaranteeing investors seamless access to transparent and efficient systems. Apart from that, subscription management and NAV accounting further bolster the operational capability, whereas institutional fee models deliver scalability and clarity for asset management firms. This joint effort makes Rayls